Search – Page 90 – Indianapolis Business Journal

Home » Search

Articles

CEO Lechleiter says Lilly in ‘most prolific period of new launches’

May 24, 2016

The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.

Elements in place to keep IMS under family ownership

May 19, 2016

Thanks to a savvy tax-avoiding maneuver by late track owner Anton “Tony” Hulman Jr., his descendants appear poised to lead the Indianapolis Motor Speedway into the next era.

Judge awards ex-Lilly manager $500,000 after lawsuit

May 9, 2016

A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.

IU’s philanthropy school sets new high for graduating class

May 5, 2016

The 2016 graduating class includes 66 students earning doctorate, masters and bachelors degrees as well as graduate certificates in philanthropic studies.

Toxicology labs face tough times

May 5, 2016 | John Russell

Deep cuts in Medicare reimbursements and competition from a few huge national chains and walk-in labs are making it tougher for Indianapolis-based AIT and other toxicology labs to compete.

Ask your doc about these award-winning ads

April 28, 2016

You can't escape drug ads, as pervasive as they are. But did you know there's an annual banquet to award the best of the lot?

Lilly sales rise, but higher costs push down profit

April 26, 2016

Lilly got a boost from a stable of new drugs but saw sales tumble for longtime stalwarts Cymbalta and Humalog. Meanwhile, R&D costs rose as the company ushered products through its late-stage pipeline.

Some prior Pence donors pull back

April 21, 2016

Many big donors who helped propel Republican Mike Pence into the Governor’s Office appear to be sitting out his re-election effort or are waiting to write checks.

PETERSON: Time is right for state-funded preschool

April 21, 2016

The case for broad, state funding for preschool has always been strong. Three recent developments make it overwhelming. First, Marion County families are demanding high-quality preschool for their children. For the second straight year, there have been more than twice as many applications for financial support as there are available scholarships. Parents care about their […]

State’s life sciences sector on rise while struggling with talent, capital

April 21, 2016

Shortages of workers and investment dollars remain the two biggest challenges for Indiana’s life sciences industry, which otherwise is showing robust vital signs and embarking on high-profile collaborations.

Bristol-Myers drug tops Lilly’s Erbitux in cancer study

April 20, 2016

Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.

Modeling agency founder Helen Wells dies at 89

April 15, 2016

Hundreds of admirers took to Facebook to remember Helen Wells, who started her agency in 1980 and provided talent to many of Indiana's top companies.

FERGUSON: Life sciences are powerful economic engine

April 14, 2016

This is an industry worth protecting, whether for economic reasons or for the benefits to patients worldwide.

HOOSIER BEACON: The legacy of Alec Clowes

April 14, 2016

Upon his arrival in Indianapolis, Clowes began aggressively pursuing research that might lead to mass-produced pharmaceuticals.

New law paves way for Indiana to fully embrace telemedicine

April 14, 2016

On July 1, Indiana will join 46 states in allowing physicians to write prescriptions after talking to patients on their laptops or smartphones, with no office visit required.

Lilly moves Alzheimer’s drug into late-stage testing

April 11, 2016

Despite numerous setbacks in finding a treatment for the disease in recent years, the Indianapolis drugmaker is gearing up for another big clinical trial.

$1B Methodist revamp might spawn housing rush

April 7, 2016

Indiana University Health hopes its $1 billion plan to expand Methodist Hospital will spawn nearby development, creating an area where employees can live adjacent to where they work.

Insulin’s surging price turns diabetes staple into luxury good

April 7, 2016

The three drugmakers that dominate the world diabetes market—Eli Lilly and Co., Novo Nordisk A/S and Sanofi—are introducing improved forms of insulin, with a price tag to match.

Jury: Security firm not liable for $60M heist from Lilly

April 6, 2016

Under Eli Lilly’s insurance policy, the National Union Fire Insurance Co. paid the drug firm more than $42 million for loss of the drugs, damage to the property and other expenses. The insurer’s lawsuit sought to recoup the money from the security firm.

Bipartisan trade secrets bill passed by U.S. Senate

April 5, 2016

The Senate easily passed a bill Monday allowing corporations to make a federal case of the theft of trade secrets, but a broader patent-law overhaul backed by businesses including Eli Lilly and Co. faces a rougher road.

« Previous 1 … 88 89 90 91 92 … 221 Next »

Search Results

4,414 results for '\"eli lilly\"'

Articles

CEO Lechleiter says Lilly in ‘most prolific period of new launches’

Elements in place to keep IMS under family ownership

Judge awards ex-Lilly manager $500,000 after lawsuit

IU’s philanthropy school sets new high for graduating class

Toxicology labs face tough times

Ask your doc about these award-winning ads

Lilly sales rise, but higher costs push down profit

Some prior Pence donors pull back

PETERSON: Time is right for state-funded preschool

State’s life sciences sector on rise while struggling with talent, capital

Bristol-Myers drug tops Lilly’s Erbitux in cancer study

Modeling agency founder Helen Wells dies at 89

FERGUSON: Life sciences are powerful economic engine

HOOSIER BEACON: The legacy of Alec Clowes

New law paves way for Indiana to fully embrace telemedicine

Lilly moves Alzheimer’s drug into late-stage testing

$1B Methodist revamp might spawn housing rush

Insulin’s surging price turns diabetes staple into luxury good

Jury: Security firm not liable for $60M heist from Lilly

Bipartisan trade secrets bill passed by U.S. Senate